{"DataElement":{"publicId":"7590848","version":"1","preferredName":"Tumor Marker Status","preferredDefinition":"An indication of the status of a patient's tumor markers.","longName":"TMR_MARK_STATUS","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"7590755","version":"1","preferredName":"Tumor Marker Status","preferredDefinition":"A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer)._A condition or state at a particular time.","longName":"2443094v1.0:2320064v1.0","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2443094","version":"1","preferredName":"Tumor Marker","preferredDefinition":"A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.","longName":"C17220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0A400EF7-3DF6-3538-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-01-16","endDate":null,"createdBy":"PWEST","dateCreated":"2006-01-16","modifiedBy":"ONEDATA","dateModified":"2006-01-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCCD9FAC-02FD-41F7-E053-4EBD850A289C","latestVersionIndicator":"Yes","beginDate":"2021-03-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-05","modifiedBy":"SPRINGERL","dateModified":"2021-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7589270","version":"1","preferredName":"Tumor Marker Status","preferredDefinition":"A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer)._A condition or state at a particular time.","longName":"7589270v1.0","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"300","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Unable to Assess","valueDescription":"Cannot Be Assessed","ValueMeaning":{"publicId":"2897789","version":"1","preferredName":"Cannot Be Assessed","longName":"2897789","preferredDefinition":"Aspects of the context prevent the evaluation needed to determine a value.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cannot Be Assessed","conceptCode":"C48657","definition":"Aspects of the context prevent the evaluation needed to determine a value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B943018-A5FF-1429-E040-BB89AD4312C2","latestVersionIndicator":"Yes","beginDate":"2009-06-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC991A0F-E341-2624-E053-4EBD850A47F3","beginDate":"2021-03-02","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-02","modifiedBy":"ONEDATA","dateModified":"2021-03-02","deletedIndicator":"No"},{"value":"Elevated","valueDescription":"Elevated","ValueMeaning":{"publicId":"2676306","version":"1","preferredName":"Elevated","longName":"2676306","preferredDefinition":"Elevated; raised or increased.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Elevated","conceptCode":"C25493","definition":"Raised or increased above normal levels or limits.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"38FDD1BD-2EC8-64CE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-08-31","endDate":null,"createdBy":"ALEYR","dateCreated":"2007-08-31","modifiedBy":"SOKKERL","dateModified":"2023-12-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC991A0F-E34B-2624-E053-4EBD850A47F3","beginDate":"2021-03-02","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-02","modifiedBy":"ONEDATA","dateModified":"2021-03-02","deletedIndicator":"No"},{"value":"Normal","valueDescription":"Normal","ValueMeaning":{"publicId":"4494160","version":"1","preferredName":"Normal","longName":"4494160","preferredDefinition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Normal","conceptCode":"C14165","definition":"Being approximately average or within certain limits; conforming with or constituting a norm or standard or level or type or social norm.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"043C792C-06A7-5C4A-E050-BB89AD433FD8","latestVersionIndicator":"Yes","beginDate":"2014-09-29","endDate":null,"createdBy":"RODGERSC","dateCreated":"2014-09-29","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BC991A0F-E355-2624-E053-4EBD850A47F3","beginDate":"2021-03-02","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-02","modifiedBy":"ONEDATA","dateModified":"2021-03-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435021","version":"1","preferredName":"Diagnostic or Prognostic Factor","preferredDefinition":"Top level term which includes Biological Markers, Risk Factors, and Prognostic Factors.","longName":"C20047","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741C99A-9B70-231B-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"7589269","version":"1","preferredName":"Tumor Marker Status","preferredDefinition":"A substance that may be found in tumor tissue or released from a tumor into the blood or other body fluids. A high level of a tumor marker may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (in ovarian cancer), CA 15-3 (in breast cancer), CEA (in ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (in prostate cancer).:A condition or state at a particular time.","longName":"C17220:C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC991A0F-E319-2624-E053-4EBD850A47F3","latestVersionIndicator":"Yes","beginDate":"2021-03-02","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-02","modifiedBy":"ONEDATA","dateModified":"2021-03-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BC991A0F-E32A-2624-E053-4EBD850A47F3","latestVersionIndicator":"Yes","beginDate":"2021-03-02","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-02","modifiedBy":"SPRINGERL","dateModified":"2021-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[],"ReferenceDocuments":[{"name":"Status of Tumor Markers:","type":"Preferred Question Text","description":"Status of Tumor Markers:","url":null,"context":"COG"},{"name":"COG CRF Text 1","type":"Alternate Question Text","description":"Tumor Marker Status:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BCCD2903-FEF3-792A-E053-4EBD850A083E","latestVersionIndicator":"Yes","beginDate":"2021-03-05","endDate":null,"createdBy":"SPRINGERL","dateCreated":"2021-03-05","modifiedBy":"SPRINGERL","dateModified":"2021-03-23","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}